Effect of Roflumilast on Airway Blood Flow as an Expression of Airway Inflammation in COPD
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The objectives of the proposed study are to determine 1) the effect of a single dose of
Roflumilast on airway blood flow (Qaw) (study period 1) and 2) the effect of long-term
Roflumilast treatment on airway blood flow reactivity delta Qaw)(study period 2) in patients
with stable COPD who use ICS regularly.